Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16

References

1. Chan S. Y., Ho L., Ong C. K., Chow V., Drescher B., Durst M., ter Meulen J., Villa L., Luande J., Mgaya H. N., Bernard H. U. 1992; Molecular variants of human papillomavirus-16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. Journal of Virology 66:2057–2066
   [Google Scholar]
2. Dürst M., Gissmann L., Ikenberg H., zur Hausen H. 1983; A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences, U.S.A. 80:3812–3815
   [Google Scholar]
3. Dürst M., Dzarlieva-Petrusevska R. T., Boukamp P., Fusenig N. E., Gissmann L. 1987; Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1:251–256
   [Google Scholar]
4. Firzlaff J. M., Galloway D. A., Eisenmann R. N., Luscher B. 1989; The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biologist 1:44–53
   [Google Scholar]
5. Icenogle J. P., Sathya P., Miller D. L., Tucker R. A., Rawls W. E. 1991; Nucleotide and amino acid sequence variation in the LI and E7 open reading frames of human papillomavirus type 6 and 16. Virology 184:101–107
   [Google Scholar]
6. Jones R. E., Wegrzyn R. J., Patrick D. R., Balishin N. L., Vuocolo G. A., Riemen M. W., Defoe-Jones D., Garsky V. M., Heimbrook D. C., Oliff A. 1990; Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. Journal of Biological Chemistry 265:12782–12785
   [Google Scholar]
7. Kretz K. A., Carson G. S., O’Brian J. S. 1989; Direct sequencing from low-melt agarose with Sequenase. Nucleic Acids Research 17:5864
   [Google Scholar]
8. Lorincz A. T., Temple G. F., Kurman R. J., Jenson A. B., Lancaster W. D. 1987; Oncogenic association of specific human papillomavirus types with cervical neoplasia. Journal of the National Cancer Institute 79:671–677
   [Google Scholar]
9. Müller M., Gausepohl H., de Martynoff G., Frank R., Brasseur R., Gissmann L. 1990; Identification of seroreactive regions of the human papillomavirus type 16 proteins E4, E6, E7 and LI. Journal of General Virology 71:2709–2717
   [Google Scholar]
10. Müller M., Viscidi R. P., Sun Y., Guerrero E., Hill P., Shah F., Bosch F. X., Munoz N., Gissmann L., Shah K. V. 1992; Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology 187:508–514
    [Google Scholar]
11. Seedorf K., Krammer G., Durst M., Suhai M., Rowekamp W. G. 1985; Human papillomavirus type 16 sequence. Virology 145:181–185
    [Google Scholar]
12. Storey A., Almond N., Osborn K., Crawford L. 1990; Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. Journal of General Virology 71:965–970
    [Google Scholar]
13. Ter Meulen J., Eberhardt H. C., Luande J., Mgaya H. N., Chang-Claude J., Mtiro H., Mhina M., Kashaua P., Ockert S., Yu X., Meinhardt G., Gissmann L., Pawlita M. 1992; Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, East Africa.. International Journal of Cancer (in press)
    [Google Scholar]
14. Tsunokawa Y., Takebe N., Nozawa S., Kasamatsu T., Gissmann L., zur Hausen H., Terada M., Sugimura T. 1986; Presence of human papillomavirus type 16 and 18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. International Journal of Cancer 37:499–503
    [Google Scholar]
15. Zur Hausen H. 1991; Viruses in human cancers. Science 254:1167–1173
    [Google Scholar]